Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mega Dose Vitamin C in Critically Ill COVID-19 Patients
NCT04682574Completed
- Sponsor
- The University of Lahore
- Start
- Nov 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing vitamin C with Placebo (2 arms). Primary endpoints: Partial pressure of Oxygen in arterial blood to fraction of inspired Oxygen ratio at Day 4 and Survival analysis at 28 days. Started Nov 2020; status: completed.
02
Drugs
ascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04682574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682574.